OSX ASX Chart
Snapshot
Osteopore Limited (OSX) is a regenerative medicine company and a global leader in 3D-printed biomimetic and bioresorbable implants. It seeks to commercialise products that stimulate natural bone healing across multiple segments and creates patented scaffolds using 3D-printed biomimetic and bioresorbable materials to guide and nurture bone-forming cells.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | -66.09% |
vs ASX 200 (1yr) | -76.13% |
Announcements
Corporate Overview
Corporate Details
Head Office | Perth WA 6000 |
Website | www.osteopore.com |
Registry | Automic Group |
Auditor | Grant Thornton Audit Pty Ltd |
Date Listed | 23 Sep 2019 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/02/2025 | Report (Prelim) |
15/04/2025 | Report (Annual) |
29/08/2025 | Report (Interim) |
Former Company Names
- Osteopore Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
OSX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of OSX directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Citicorp Nominees Pty Ltd | 22/03/2024 | 989,564 | 9.58 |
BNP Paribas Nominees Pty Ltd | 22/03/2024 | 703,551 | 6.81 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
08-05-24 | Advance Opportunities Fund I | 9,027,863 | -- | 8.26 |
08-05-24 | Edge Capital Fund SPC | 7,461,000 | -- | 6.85 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
17-07-24 | Edge Capital Fund SPC | 7,461,000 | 6.85 | -- |
10-05-24 | Advance Opportunities Fund I | 9,027,863 | 8.26 | -- |
27-03-24 | Irene Ng Ai Chen | 10,102,625 | 8.61 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.058 | 28 June |
2023 | $0.085 | 30 June |
2022 | $0.115 | 30 June |
2021 | $0.465 | 30 June |
2020 | $0.40 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.